Concepedia

Joseph S. Warmus

JS

Statistics

Publications

37

Citations

2.2K

H-Index

26

Active since

1987

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Colorado State University

Granta Design (United Kingdom)

Molecular Discovery (United Kingdom)

Joseph S. Warmus is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1987–2021

37

Publications

37

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition

Jeffrey F. Ohren, Huifen Chen, A.G. Pavlovsky et al. · Nature Structural & Molecular Biology · 2004 · 621 citations

, , +9

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901

Stephen D. Barrett, Alexander J. Bridges, David T. Dudley et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 286 citations

, , +9

Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections

Matthew F. Brown, Usa Reilly, J. A. Abramite et al. · Journal of Medicinal Chemistry · 2011 · 98 citations · Full text

, , +11

A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related Analogs

Elizabeth A. Lunney, Susan E. Hagen, John M. Domagala et al. · Journal of Medicinal Chemistry · 1994 · 89 citations · Full text

, , +17

Enantioselective synthesis of the bottom half of chlorothricolide. 3. Studies of the steric directing group strategy for stereocontrol in intramolecular Diels-Alder reactions

William Roush, Masanori Kageyama, Renata Riva et al. · The Journal of Organic Chemistry · 1991 · 74 citations

, , +6

1–5 of 37